NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 32 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2014. The put-call ratio across all filers is 1.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $189,000 | +158.9% | 55,000 | 0.0% | 0.10% | +182.4% |
| Q2 2015 | $73,000 | +58.7% | 55,000 | 0.0% | 0.03% | +70.0% |
| Q1 2015 | $46,000 | +109.1% | 55,000 | 0.0% | 0.02% | 0.0% |
| Q4 2014 | $22,000 | -83.2% | 55,000 | +83.3% | 0.02% | -83.1% |
| Q3 2014 | $131,000 | -12.1% | 30,000 | 0.0% | 0.12% | -1.7% |
| Q2 2014 | $149,000 | -30.0% | 30,000 | -23.3% | 0.12% | -25.0% |
| Q1 2014 | $213,000 | -15.8% | 39,100 | -6.1% | 0.16% | -12.6% |
| Q4 2013 | $253,000 | -58.8% | 41,650 | -55.1% | 0.18% | -65.3% |
| Q3 2013 | $614,000 | +30.6% | 92,700 | 0.0% | 0.53% | +31.4% |
| Q2 2013 | $470,000 | – | 92,700 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 41,650 | $253,000 | 0.18% |
| Eidelman Virant Capital | 27,796 | $169,000 | 0.07% |
| WMS Partners, LLC | 63,350 | $384,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 62,742 | $381,000 | 0.05% |
| Brown Advisory Securities, LLC | 10,000 | $61,000 | 0.02% |
| CROFT-LEOMINSTER INC | 20,000 | $121,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 15,479 | $94,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $152,000 | 0.01% |
| CANADA PENSION PLAN INVESTMENT BOARD | 120,913 | $734,000 | 0.00% |
| Virtu KCG Holdings LLC | 23,325 | $140,000 | 0.00% |